Clinical trial
A Clinical Trial of Infliximab for Uveitis
NCT00273390 · Oregon Health and Science University, Other · Completed
Key facts
| NCT number | NCT00273390 |
|---|---|
| Title | A Clinical Trial of Infliximab for Uveitis |
| Official title | The Use of Remicade (Infliximab) in the Management of Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression |
| Lead sponsor | Oregon Health and Science University, Other |
| Collaborators | Centocor, Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Uveitis |
| Intervention type | Drug |
| Interventions | Remicade (infliximab) |
| Enrollment | 32 |
| Start date | Aug 1, 2001 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Jul 4, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: